LAUSR

Small bowel neuroendocrine tumours (SBNETs) are increasingly prevalent in surgical practice, with approximately 0.67 cases per 100,000 population in the United Sates [1]. Patients with SBNETs often present at advanced stages, when obstruction, pain, bleeding, and symptoms associated with metastatic carcinoid syndrome arise. The gold standard surgical management of SBNETs is an exploratory laparotomy and resection, with thorough palpation of the entire jejunum and ileum to identify sub-centimetre multifocal tumours [2]. Although minimally invasive surgical techniques are discouraged as primary interventions for SBNETs, they may prove useful in continued management of these cases and their potential complications [3].